CENTER FOR SYNTHETIC BIOLOGY

Northwestern scientists have been blazing new trails in synthetic biology — an innovative marriage of engineering, physics and biological systems — for nearly two decades. Attracting world-class faculty and a growing NIH funding, CSB was established as a nexus of this emerging field that is poised to transform medicine, energy and more. With a recent $18.5 million grant from the U.S. Department of Energy, Northwestern continues to lead in this space.

CHEMISTRY OF LIFE PROCESSES INSTITUTE

Home of the blockbuster drug Lyrica®, CLP is now on an ambitious quest to sequence proteins on the scale of the Human Genome Project. Ushering in a new era of personalized medicine, the institute is at the forefront of proteomics, a revolutionary and fast-growing field that identifies and measures proteins, linking genes and diseases to diagnose and treat threats to human health.

ROBERT H. LURIE COMPREHENSIVE CANCER CENTER

One of the rigorously selected National Cancer Institute (NCI)-designated Comprehensive Cancer Centers, the Lurie Cancer Center has recently received NCI’s highest rating — overall “exceptional” — along with an estimated $30 million in core funding to build on its 50 years of breakthrough research leading to better ways of preventing, diagnosing and treating cancer.

INSTITUTE FOR PUBLIC HEALTH AND MEDICINE

A powerhouse of public health research at the Feinberg School of Medicine, IPHAM sheds critical light on societal ails ranging from health disparities to food allergies to the opioid crisis and more. Working closely with Chicago communities while uncovering data that has national impact, IPHAM changes lives every day through interdisciplinary collaborations that cut across medicine, social sciences and technology.

Learn more about IPHAM